DaVita Dirección

Dirección controles de criterios 3/4

El CEO de DaVita's es Javier Rodriguez , nombrado en Jun 2019, tiene una permanencia de 4.83 años. compensación anual total es $2.98M, compuesta por 40.2% salario y 59.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.8% de las acciones de la empresa, por valor de $93.46M. La antigüedad media del equipo directivo y de la junta directiva es de 5.7 años y 4.8 años, respectivamente.

Información clave

Javier Rodriguez

Chief Executive Officer (CEO)

US$6.7m

Compensación total

Porcentaje del salario del CEO	21.0%
Permanencia del CEO	4.9yrs
Participación del CEO	0.8%
Permanencia media de la dirección	4.9yrs
Promedio de permanencia en la Junta Directiva	4.9yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Javier Rodriguez en comparación con los beneficios de DaVita?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	US$816m
Dec 31 2023	US$7m	US$1m	US$692m
Sep 30 2023	n/a	n/a	US$596m
Jun 30 2023	n/a	n/a	US$454m
Mar 31 2023	n/a	n/a	US$500m
Dec 31 2022	US$3m	US$1m	US$547m
Sep 30 2022	n/a	n/a	US$680m
Jun 30 2022	n/a	n/a	US$834m
Mar 31 2022	n/a	n/a	US$903m
Dec 31 2021	US$3m	US$1m	US$978m
Sep 30 2021	n/a	n/a	US$984m
Jun 30 2021	n/a	n/a	US$883m
Mar 31 2021	n/a	n/a	US$791m
Dec 31 2020	US$73m	US$1m	US$783m
Sep 30 2020	n/a	n/a	US$832m
Jun 30 2020	n/a	n/a	US$824m
Mar 31 2020	n/a	n/a	US$816m
Dec 31 2019	US$17m	US$1m	US$705m
Sep 30 2019	n/a	n/a	US$623m
Jun 30 2019	n/a	n/a	US$548m
Mar 31 2019	n/a	n/a	US$551m
Dec 31 2018	US$8m	US$900k	US$616m
Sep 30 2018	n/a	n/a	US$617m
Jun 30 2018	n/a	n/a	US$698m
Mar 31 2018	n/a	n/a	US$652m
Dec 31 2017	US$8m	US$900k	US$909m

Compensación vs. Mercado: La compensación total ($USD6.71M) de Javier está en línea con el promedio de empresas de tamaño similar en el mercado UK ($USD5.65M).

Compensación vs. Ingresos: La compensación de Javier ha aumentado más de un 20% en el último año.

CEO

Javier Rodriguez (52 yo)

4.9yrs

Permanencia

US$6,712,328

Compensación

Mr. Javier J. Rodriguez serves as an Independent Director at Gilead Sciences, Inc. since June 15, 2020. He has been Chief Executive Officer and Executive Director of DaVita Inc. since June 1, 2019. Mr. Rod...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Javier Rodriguez	CEO & Executive Director	4.9yrs	US$6.71m	0.80% $ 94.6m
Joel Ackerman	CFO & Treasurer	7.3yrs	US$6.87m	0.16% $ 18.9m
Kathleen Waters	Chief Legal & Public Affairs Officer	8yrs	US$5.61m	0.068% $ 8.0m
James Hearty	Chief Compliance Officer	6.2yrs	US$2.73m	0.014% $ 1.6m
Michael Staffieri	Chief Operating Officer of Kidney Care	10.2yrs	US$10.42m	0.23% $ 27.1m
Christopher Berry	Group VP & Chief Accounting Officer	less than a year	sin datos	sin datos
Misha Palecek	Chief Transformation Officer of U.S. Kidney Care Business	no data	sin datos	sin datos
Jeffrey Giullian	Chief Medical Officer of Kidney Care	4.3yrs	sin datos	sin datos
Partha Das	Chief Medical Officer of DaVita International	5.8yrs	sin datos	sin datos
Mandy Hale	Chief Nursing Officer	3.9yrs	sin datos	sin datos
Tina Livaudais	Chief Nursing Officer of Kidney Care	2.7yrs	sin datos	sin datos
Mihran Naljayan	Chief Medical Officer of Home Modalities & Pediatrics	2.3yrs	sin datos	sin datos

4.9yrs

Permanencia media

53yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 0I7E se considera experimentado (4.9 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Javier Rodriguez	CEO & Executive Director	4.9yrs	US$6.71m	0.80% $ 94.6m
John Nehra	Independent Director	23.5yrs	US$344.96k	0.089% $ 10.5m
Charles Berg	Director	17.2yrs	US$322.46k	0.029% $ 3.4m
Barbara Desoer	Independent Director	8.6yrs	US$384.96k	0.018% $ 2.1m
Phyllis Yale	Independent Director	7.8yrs	US$374.96k	0.017% $ 2.0m
Wendy Schoppert	Independent Director	less than a year	US$106.86k	0.00093% $ 109.7k
Pamela Arway	Independent Chair	15yrs	US$497.46k	0.027% $ 3.2m
Dennis Pullin	Independent Director	less than a year	sin datos	sin datos
Adam Schechter	Independent Director	1.7yrs	US$334.96k	0.0030% $ 352.6k
Jason Hollar	Independent Director	2yrs	US$364.96k	0.0040% $ 475.2k
Gregory Moore	Independent Director	2.7yrs	US$355.89k	0.0054% $ 637.9k

4.9yrs

Permanencia media

63yo

Promedio de edad

Junta con experiencia: La junta directiva de 0I7E se considera experimentada (4.8 años de antigüedad promedio).

DaVita Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

DaVita Inc., Annual General Meeting, Jun 06, 2024

High number of new directors

Davita Announces Dennis Pullin to Its Board of Directors

Chief Compliance Officer recently sold US$3.0m worth of stock

DaVita Inc. Announces Management Changes

Chief Legal & Public Affairs Officer recently sold US$1.0m worth of stock

Recent updates

New major risk - Financial position

DaVita Inc., Annual General Meeting, Jun 06, 2024

High number of new directors

DaVita Inc. to Report Q1, 2024 Results on May 02, 2024

Davita Announces Dennis Pullin to Its Board of Directors

Chief Compliance Officer recently sold US$3.0m worth of stock

Full year 2023 earnings released: EPS: US$7.62 (vs US$5.88 in FY 2022)

DaVita Inc. to Report Q4, 2023 Results on Feb 13, 2024

Investor sentiment improves as stock rises 15%

New major risk - Financial position

Third quarter 2023 earnings released: EPS: US$2.70 (vs US$1.16 in 3Q 2022)

DaVita Inc. to Report Q3, 2023 Results on Nov 07, 2023

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

New major risk - Financial position

Second quarter 2023 earnings released: EPS: US$1.96 (vs US$2.38 in 2Q 2022)

DaVita Inc. Announces Management Changes

DaVita Inc. to Report Q2, 2023 Results on Aug 03, 2023

Chief Legal & Public Affairs Officer recently sold US$1.0m worth of stock

First quarter 2023 earnings released: EPS: US$1.28 (vs US$1.68 in 1Q 2022)

Director recently sold US$108k worth of stock

Full year 2022 earnings released: EPS: US$5.88 (vs US$9.30 in FY 2021)

DaVita Inc. to Report Q4, 2022 Results on Feb 22, 2023

Independent Director recently bought US$356k worth of stock

Second quarter 2022 earnings released: EPS: US$2.38 (vs US$2.76 in 2Q 2021)

Investor sentiment deteriorated over the past week

DaVita Inc. to Report Q3, 2022 Results on Oct 28, 2022

DaVita Inc. Appoints Adam H. Schechter to Board of Directors

Second quarter 2022 earnings released: EPS: US$2.38 (vs US$2.76 in 2Q 2021)

DaVita Inc. to Report Q2, 2022 Results on Aug 01, 2022

Chief Operating Officer of Kidney Care recently bought US$1.6m worth of stock

Independent Director recently sold US$226k worth of stock

DaVita Inc., Annual General Meeting, Jun 09, 2022

First quarter 2022 earnings released: EPS: US$1.68 (vs US$2.18 in 1Q 2021)

DaVita Inc. to Report Q1, 2022 Results on May 05, 2022

DaVita Inc. Appoints Jason M. Hollar as Independent Director

Independent Director recently sold US$80k worth of stock

DaVita Inc. (NYSE:DVA) acquired 17 Dialysis Centers in United States.

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

DaVita Inc. to Report Q4, 2021 Results on Feb 10, 2022

DaVita Inc. (NYSE:DVA) acquired MedSleuth, Inc.

Third quarter 2021 earnings released: EPS US$2.48 (vs US$1.31 in 3Q 2020)

Independent Director recently sold US$105k worth of stock

Second quarter 2021 earnings released: EPS US$2.76 (vs US$1.65 in 2Q 2020)

DaVita Inc. (NYSE:DVA) acquired a Dialysis Center in US.

Davita's China Affiliate to Invest in Hunan Fangsheng Pharma's Unit for 31.7% Stake

First quarter 2021 earnings released: EPS US$2.18 (vs US$1.84 in 1Q 2020)

Revenue misses expectations

Full year 2020 earnings released: EPS US$6.54 (vs US$4.61 in FY 2019)

Kyros Law Files Legal Claims on Behalf of Davita Inc Investors

DaVita Inc. to Report Q4, 2020 Results on Feb 11, 2021

Renalytix AI plc and DaVita Announce Partnership

DaVita Inc. Announces Management Changes, with Effect from December 15, 2020

Chief Legal Officer recently sold US$1.1m worth of stock

Third quarter earnings released

Third-quarter earnings released: Revenue misses expectations

DaVita Inc. to Report Q3, 2020 Results on Oct 29, 2020

DaVita Inc. Announces the Retirement of Leanne M. Zumwalt, Group Vice President, Government Affairs

An unknown buyer acquired RMS Lifeline, Inc. from DaVita Inc. (NYSE:DVA).

DaVita Inc. to Report Q2, 2020 Results on Jul 30, 2020

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media